Detalles de la búsqueda
1.
Small-Molecule Cyclophilin Inhibitors Potently Reduce Platelet Procoagulant Activity.
Int J Mol Sci
; 24(8)2023 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37108326
2.
A Phenyl-Pyrrolidine Derivative Reveals a Dual Inhibition Mechanism of Myocardial Mitochondrial Permeability Transition Pore, Which Is Limited by Its Myocardial Distribution.
J Pharmacol Exp Ther
; 376(3): 348-357, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33303698
3.
Inhibition of SARS-CoV-2 Infection by the Cyclophilin Inhibitor Alisporivir (Debio 025).
Antimicrob Agents Chemother
; 64(7)2020 06 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-32376613
4.
MK-571, a Cysteinyl Leukotriene Receptor 1 Antagonist, Inhibits Hepatitis C Virus Replication.
Antimicrob Agents Chemother
; 64(6)2020 05 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32179525
5.
Small-Molecule Inhibitors of Cyclophilins Block Opening of the Mitochondrial Permeability Transition Pore and Protect Mice From Hepatic Ischemia/Reperfusion Injury.
Gastroenterology
; 157(5): 1368-1382, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31336123
6.
Characterization of the Anti-Hepatitis C Virus Activity of New Nonpeptidic Small-Molecule Cyclophilin Inhibitors with the Potential for Broad Anti-Flaviviridae Activity.
Antimicrob Agents Chemother
; 62(7)2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29760125
7.
Inhibition of RNA binding to hepatitis C virus RNA-dependent RNA polymerase: a new mechanism for antiviral intervention.
Nucleic Acids Res
; 42(14): 9399-409, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25053847
8.
Structure-activity relationships in the development of allosteric hepatitis C virus RNA-dependent RNA polymerase inhibitors: ten years of research.
Med Res Rev
; 33(5): 934-84, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22893620
9.
The novel cyclophilin inhibitor C105SR reduces hepatic ischaemia-reperfusion injury via mitoprotection.
JHEP Rep
; 5(11): 100876, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37860051
10.
Third Early "Booster" Dose Strategy in France of bnt162b2 SARS-CoV-2 Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients Enhances Neutralizing Antibody Responses.
Viruses
; 14(9)2022 08 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36146735
11.
Desloratadine, an FDA-approved cationic amphiphilic drug, inhibits SARS-CoV-2 infection in cell culture and primary human nasal epithelial cells by blocking viral entry.
Sci Rep
; 12(1): 21053, 2022 12 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36473907
12.
Proviral role of human respiratory epithelial cell-derived small extracellular vesicles in SARS-CoV-2 infection.
J Extracell Vesicles
; 11(10): e12269, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36271885
13.
The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy Individuals.
Cancer Discov
; 12(4): 958-983, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35179201
14.
Silibinin and related compounds are direct inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
Gastroenterology
; 138(3): 1112-22, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19962982
15.
Real-world efficacy and safety of direct-acting antiviral drugs in patients with chronic hepatitis C and inherited blood disorders.
Eur J Gastroenterol Hepatol
; 33(1S Suppl 1): e191-e196, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33208686
16.
Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis.
Cell Death Differ
; 28(12): 3297-3315, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34230615
17.
Characterization of V36C, a novel amino acid substitution conferring hepatitis C virus (HCV) resistance to telaprevir, a potent peptidomimetic inhibitor of HCV protease.
Antimicrob Agents Chemother
; 54(6): 2681-3, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20368394
18.
Fitness-associated substitutions following failure of direct-acting antivirals assessed by deep sequencing of full-length hepatitis C virus genomes.
Aliment Pharmacol Ther
; 52(10): 1583-1591, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32886807
19.
Nonprenylated rotenoids, a new class of potent breast cancer resistance protein inhibitors.
J Med Chem
; 50(8): 1933-8, 2007 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-17341062
20.
Flavonoid structure-activity studies identify 6-prenylchrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2.
Cancer Res
; 65(11): 4852-60, 2005 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15930306